Unknown

Dataset Information

0

Major pathological response after neoadjuvant immunotherapy in esophageal spindle cell carcinoma: A case report.


ABSTRACT: Esophageal spindle cell carcinoma (ESpCC) is a rare subtype of esophageal carcinoma, accounting for 1% of all esophageal malignancies. The clinical outcome is unknown due to the lack of treatment options. Here, we present the case of a 60-year-old male with initially unresectable ESpCC, in which platinum-based concurrent chemoradiotherapy was unsuccessful. He was subsequently treated with neoadjuvant immunotherapy and after surgery achieved a complete pathological response; therefore, neoadjuvant immunotherapy might be a novel option for ESpCC patients.

SUBMITTER: Fu Y 

PROVIDER: S-EPMC8046125 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8334861 | biostudies-literature
| S-EPMC4050419 | biostudies-literature
| S-EPMC10928968 | biostudies-literature
| S-EPMC8576689 | biostudies-literature
| S-EPMC6106005 | biostudies-other
| S-EPMC10985969 | biostudies-literature
| S-EPMC8695578 | biostudies-literature
2014-01-01 | E-GEOD-43519 | biostudies-arrayexpress
| S-EPMC9545900 | biostudies-literature
| S-EPMC8033340 | biostudies-literature